Evidence map›Paper›PMID 37163509›Full record

ArticlePloS one2023

A validated protocol to UV-inactivate SARS-CoV-2 and herpesvirus-infected cells.

Timothy K Soh, Susanne Pfefferle, Stephanie Wurr, Ronald von Possel, Lisa Oestereich, Toni Rieger, Charlotte Uetrecht, Maria Rosenthal, Jens B Bosse

Abstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Findings and Recommendations of the RAV3N Applied Biorisk and Biosafety Gap Assessment Workshop.Applied biosafety : journal of the American Biological Safety Association · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Timothy K SohCentre for Structural Systems Biology, Hamburg, Germany.
Susanne PfefferleDepartment of Virology, Bernhard-Nocht Institute for Tropical Medicine, Hamburg, Germany.
Stephanie WurrDepartment of Virology, Bernhard-Nocht Institute for Tropical Medicine, Hamburg, Germany.
Ronald von PosselDepartment of Virology, Bernhard-Nocht Institute for Tropical Medicine, Hamburg, Germany.ORCID 0000-0001-9422-9401
Lisa OestereichDepartment of Virology, Bernhard-Nocht Institute for Tropical Medicine, Hamburg, Germany.
Toni RiegerDepartment of Virology, Bernhard-Nocht Institute for Tropical Medicine, Hamburg, Germany.
Charlotte UetrechtCentre for Structural Systems Biology, Hamburg, Germany.
Maria RosenthalCentre for Structural Systems Biology, Hamburg, Germany.ORCID 0000-0003-2986-936X
Jens B BosseCentre for Structural Systems Biology, Hamburg, Germany.ORCID 0000-0001-7252-5541

Funding

Wellcome Trust 209250/Z/17/Z
6 · The paper itself

Abstract

Downstream analysis of virus-infected cell samples, such as reverse transcription polymerase chain reaction (RT PCR) or mass spectrometry, often needs to be performed at lower biosafety levels than their actual cultivation, and thus the samples require inactivation before they can be transferred. Common inactivation methods involve chemical crosslinking with formaldehyde or denaturing samples with strong detergents, such as sodium dodecyl sulfate. However, these protocols destroy the protein quaternary structure and prevent the analysis of protein complexes, albeit through different chemical mechanisms. This often leads to studies being performed in over-expression or surrogate model systems. To address this problem, we generated a protocol that achieves the inactivation of infected cells through ultraviolet (UV) irradiation. UV irradiation damages viral genomes and crosslinks nucleic acids to proteins but leaves the overall structure of protein complexes mostly intact. Protein analysis can then be performed from intact cells without biosafety containment. While UV treatment protocols have been established to inactivate viral solutions, a protocol was missing to inactivate crude infected cell lysates, which heavily absorb light. In this work, we develop and validate a UV inactivation protocol for SARS-CoV-2, HSV-1, and HCMV-infected cells. A fluence of 10,000 mJ/cm2 with intermittent mixing was sufficient to completely inactivate infected cells, as demonstrated by the absence of viral replication even after three sequential passages of cells inoculated with the treated material. The herein described protocol should serve as a reference for inactivating cells infected with these or similar viruses and allow for the analysis of protein quaternary structure from bona fide infected cells.

Indexed as

COVID-19HerpesviridaeHumansSARS-CoV-2Ultraviolet RaysVirus InactivationVirus Replication

Identifiers

PMID37163509
PMCPMC10171616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.